Cataract and IOLs | Clinical Optics | Corneal and Anterior Segment Disease | Glaucoma | Neuro-ophthalmology | Oculoplastics
Ophthalmic Pathology | Pain Management | Pediatric Ophthalmology | Refractive Surgery | Retina | Risk Management

Click here for highlights of OSN Las Vegas 2006: Improving Your Odds

Click here for highlights of Hawaii 2006: The Royal Hawaiian Eye Meeting

Click here for highlights of New York 2005: 14th Annual Ocular Surgery News Symposium

Click here for highlights of 9th Annual Ocular Drug and Surgical Therapy Update

Click here for highlights of Miami 2005: Neuro-Ophthalmology Update 2005

Click here for highlights of Miami 2005: Ophthalmic Risk Management and Patient Safety

Click here for highlights of Hawaii 2005: The Royal Hawaiian Eye Meeting

Click here for highlights of New York 2004: 13th Annual Ocular Surgery News Symposium

Click here for highlights of Hawaii 2004: The Royal Hawaiian Eye Meeting, Kauai, HI

Click here to see Meeting Archive

• Cataract Surgery in the Glaucoma Patient
  Louis B. Cantor, MD
  
• Phaco-NPDS: Technique
  Thomas W. Samuelson, MD
  
• Phaco-CPC: Technique
  Robert J. Noecker, MD
  
• Mixing and Matching Multifocal IOLs: A Summary of Key Studies
  Richard L. Lindstrom, MD
  
• Conventional IOL Presbyopia Correction for the Cataract Patient
  William F. Maloney, MD
  
• Optimizing Patient Outcomes with Aspheric Monofocal IOLs
  Jack T. Holladay, MD, MSEE, FACS
  
• Cataract Surgery Chemoprophylaxis: Results of the ESCRS Study
  Francis S. Mah, MD
  
• Update on Phakic IOLs
  Elizabeth A. Davis, MD, FACS
  
• Antibiotics and NSAIDs in Corneal and Lens Surgery
  Elizabeth A. Davis, MD, FACS
  
• IOL Calculations Following Corneal Refractive Surgery
  Jack T. Holladay, MD, MSEE, FACS
  
• Cataract Surgery in the Glaucoma Patient
  Louis B. Cantor, MD
  
• Presbyopic IOLs in the Glaucoma Patient
  Ike K. Ahmed, MD
  
• Keynote Lecture: Management and Prevention of Cataract Surgical Complications: A Vitreoretinal Surgeon's Perspective
  Carmen A. Puliafito, MD, MBA
  
• Panel Discussion - Cataract Surgery Complications
  Moderator: Manus C. Kraff, MD
  
• Update on Verisyse and Veriflex Phakic IOL
  R. Doyle Stulting, MD, PhD
  
• Maximizing Your Success with Phakic IOLs through Optimized Practice Implementation
  David R. Hardten, MD
  
• Advanced IOLs In a Refractive Surgery Practice
  Daniel S. Durrie, MD
  
• Surface Ablation in Eyes with Risk Factors for Ectasia
  Helen K. Wu, MD
  
• A Contralateral Clinical Trial Comparing a Mechanical Microkeratome to a Femtosecond Laser
  Hung Ming Lee, MD, FRCS
  
• Panel Discussion - What's New in Anterior Segment Surgical Technology
  Moderator: Robert H. Osher, MD
  
• Mixing and Matching Multifocal IOLs: A Summary of Key Studies
  Richard L. Lindstrom, MD
  
• Pseudophakic Cystoid Macular Edema
  Michael S. Ip, MD
• Management Strategies for Avoidance of Infectious and Inflammatory Post Surgical Complications
  John R. Wittpenn, MD
• Conventional IOL Presbyopia Correction for the Cataract Patient
  William F. Maloney, MD
  
• NSAIDs: New Agents and Changing Indications
  Edward J. Holland, MD
• Bactericidal Effect of a New Lid Foam Formulation on 40 Endophthalmitis Organisms
  Jeffrey P. Gilbard, MD
• Optimizing Patient Outcomes with Aspheric Monofocal IOLs
  Jack T. Holladay, MD, MSEE, FACS
  
• Anti-Infectives: Are Aminoglycosides Still Useful?
  Francis S. Mah, MD
• The Upside of Antibiotic Potency for Killing Pathogens vs. the Downside of Clinical Toxicity
  Robert W. Snyder, MD, PhD
• Cataract Surgery Chemoprophylaxis: Results of the ESCRS Study
  Francis S. Mah, MD
  
• Contemporary Approaches to Antibiotic Selection
  Terrence P. O'Brien, MD
• An Update on Next Generation Fluoroquinolones
  Stephen D. McLeod, MD
• Update on Phakic IOLs
  Elizabeth A. Davis, MD, FACS
  
• Cataract Surgery in the Glaucoma Patient
  Louis B. Cantor, MD
  
• Zonule and Capsule Challenges
  Priscilla E. Perry Arnold, MD
  
• Antibiotics and NSAIDs in Corneal and Lens Surgery
  Elizabeth A. Davis, MD, FACS
  
• Piggyback IOLs for Adjustment of Refractive Errors
  Elizabeth A. Davis, MD
  
• IOL Calculations Following Corneal Refractive Surgery
  Jack T. Holladay, MD, MSEE, FACS
  
• Strategies for Preventing Infection after Ophthalmic Surgical Procedures
  Francis S. Mah, MD
  
• AMO ARRAY IOL: Presbyopic Lens Exchange
  R. Bruce Wallace III, MD
  
• AquaLase Cataract Removal Techniques and Benefits
  Robert P. Lehmann, MD, FACS
  
• Bimanual Microincision Phacoemulsification with Millenium
  Richard L. Lindstrom, MD
  
• Clinical Advances in Light Adjustable IOLs
  Randall J. Olson, MD
  
• Clinical Applications of New Cataract Equipment
  Richard J. Mackool, MD
  
• Dry Eye Diagnosis and Management 2004
  Henry D. Perry, MD
  
• How to Use Different Viscoelastics to Your Advantage
  Douglas A. Katsev, MD
  
• Evolving State of Microphaco
  Randall J. Olson, MD
  
• Strategy for Using the Infiniti Vision System
  Robert J. Cionni, MD
  
• IOL Essentials for Refractive Surgery
  James P. McCulley, MD, FACS, FRC Ophth. (U.K.) · David M. Bruton, Jr. Chair in Ophthalmology
  
• Advances in IOL Materials and Designs: Maximizing Biocompatability and Optical Performance
  Terrence P. O'Brien, MD
  
• Light Adjustable Lens (LAL)
  Daniel M. Schwartz, MD
  
• Very Low Turbulence Phacoemulsification
  Lawrence A. Brierley, MD, FRCS(C), FACS
  
• Holladay 2 Formula Multifocal IOL's
  Jack T. Holladay, MD, MSEE, FACS
  
• New IOL Technology
  I. Howard Fine, MD
  
• New Phacoemulsification Technology
  I. Howard Fine, MD
  
• Power Modulation with the Millennium System
  Terence M. Devine, MD
  
• Thermal Energy, Turbulence, and Bimanual Phaco with AMO WhiteStar
  Roger F. Steinert, M
  
• Early Uncorrected Vision: An Important Measurement in Contemporary Cataract Surgery
  Robert H. Osher, MD
  
• Preventing PCO: The 2004 Update
  Steven H. Dewey, MD
  
• A Modified Prolate IOL for Reduction of Spherical Aberration
  Mark Packer, MD
  
• Pseudo-Accommodation with Thinoptic Lens Implants
  John D. Hunkeler, MD
  
• Results of the ReSTOR IOL
  Kerry D. Solomon, MD
  
• Viscoat Trap & Pars Plana Vitrectomy
  David F. Chang, MD
  
• Surgical Prophylaxis
  Edward E Manche, MD
  
• Bimanual Phaco: New Instruments and Maneuvers
  Roger F. Steinert, MD
  
• Transitioning to Bimanual Sleeveless Phaco on the Millennium
  Rosa Braga-Mele, MD, FRCSC
  
• IOL Edge Design PCO vs. Dysphotopsia
  Samuel Masket, MD
  
• Phaco "Quick Chop"
  Louis D. Nichamin, MD
  
• Intraocular Lenses in Glaucoma & Uveitis
  Thomas W. Samuelson, MD
  
• New Inserter Technology
  John D. Hunkeler, MD
  
• Use of Modified Capsular Tension Ring in Complicated Cases
  Ike K. Ahmed, MD, FRCSC · Christoph Kranemann, MD · Alan S. Crandall, MD
  
• New Cataract Removal Technology
  Richard J. Mackool, MD
  
• The Collamer: A Unique Plate Lens
  Elizabeth A. Davis, MD, FACS
  
• Advances in IOL Calculations
  Warren E. Hill, MD, FACS
  
• IOL Calculations after Refractive Surgery
  Douglas D. Koch, MD
  
• Management of Astigmatism in Conjunction with Clear Corneal Phaco Surgery
  Louis D. Nichamin, MD
  
• Multifocal IOL Design: Pros and Cons
  Richard L. Lindstrom, MD
  
• Prelex: Presbyopic Lens Exchange
  R. Bruce Wallace III, MD
  
• C&C Vision Crystal Lens™: FDA Clinical Investigation
  Mark Packer, MD
  
• The Correction of Spherical Aberration
  Mark Packer, MD
  
• Light Adjustable Lens (LAL)
  Daniel M. Schwartz, MD
  
• Investigational Update on a New Toric IOL
  Stephen S. Lane, MD
  
• The Calm after the Storm: The Case for Routine Use of NSAIDs After Cataract Surgery
  Stephen S Lane, MD
  
• New Techniques with New Viscoelastics
  Douglas A Katsev, MD
  
• Role of Fluoroquinolones in the Prevention of Endophthalmitis
  Frank A Bucci, Jr, MD
  
• Burst Hemiflip Phacoemulsification
  R Bruce Wallace, III, MD
  
• Coincident Cataract and Glaucoma: Has the Classic Teaching Become Obsolete?
  Thomas W Samuelson, MD
  
• Can IOLs Be Too Biocompatible?
  Randall J. Olson, MD
  
• Laser Cataract Surgery
  John D. Hunkeler, MD
  

None Currently Available

• Corneal Ectasia and Laser Refractive Surgery
  Elizabeth A. Davis, MD, FACS
  
• Bactericidal Effect of a New Lid Foam Formulation on 40 Endophthalmitis Organisms
  Jeffrey P. Gilbard, MD
• Anti-Infectives: Are Aminoglycosides Still Useful?
  Francis S. Mah, MD
• The Upside of Antibiotic Potency for Killing Pathogens vs. the Downside of Clinical Toxicity
  Robert W. Snyder, MD, PhD
• Contemporary Approaches to Antibiotic Selection
  Terrence P. O'Brien, MD
• An Update on Next Generation Fluoroquinolones
  Stephen D. McLeod, MD
• Update on the Treatment of Herpes Simplex Ocular Infections
  Jerold S. Gordon, MD
• Use of Fibrin Tissue Adhesive and Amnionic Membrane in Anterior Segment Surgery
  John Hovanesian, MD
• The Cornea and its Emerging Role as the Refining Element in Refractive Surgery
  Louis D. Nichamin. MD
  
• A Comparative Prospective Study of LASIK Flap Creation with IntraLase FS30 Laser vs. Hansatome Microkeratome
  Elizabeth A. Davis, MD
  
• Antibiotic Prophylaxis for Post-Surgical Infections
  John R. Wittpenn, MD, FAAO
  
• Cyclosporine Therapy for Dry Eye (Cyclosporine Ophthalmic Emulsion 0.05%)
  Michael B. Raizman, MD
  
• Dietary Omega-3 Fatty Acid Intake & Risk of Clinically Diagnosed Dry Eye Syndrome in Women
  Jeffrey P. Gilbard, MD
  
• LASIK-Associated Infections: The Next Step in Prevention and Management
  Terry Kim, MD
  
• Management of Bacterial Infections of the Cornea: Embracing the New Frontier
  Terrence P. O'Brien, MD
  
• New Strategies in the Prevention of Post-Cataract Endophthalmitis
  Eric D. Donnenfeld, MD
  
• New Antibiotic Therapy Beyond Vigamox™ and Zymar™
  Francis S. Mah, MD
  
• Overview of Herpesviruses
  Jerold S. Gordon, MD
  
• Pharmacokinetics of 4th Generation Fluoroquinolones: Tissue and Fluid Concentrations Over Time
  James P. McCulley, MD, FACS, FRC Ophth. (U.K.); David M. Bruton, Jr.
  
• Prevention and Management of Post-LASIK Dry Eye
  Eric D. Donnenfeld, MD
  
• Update on Allergy Therapy
  Michael B. Raizman, MD
  
• Dry Eye: Is Cyclosporine the Key?
  John R. Wittpenn Jr, MD
  
• Fluoroquinolones: Where Are We Today?
  John R. Wittpenn Jr, MD
  
• Penetration of Ocular Antibiotics
  Calvin W. Roberts, MD
  
• Newer Horizons in Ocular Antibacterial Therapy
  Terrence P. O Brian, MD
  
• My Approach to Dry Eye
  Douglas A. Katsev, MD
  
• New Allergy Drugs
  Michael B. Raizman, MD
  
• Topical Cyclosporine A for the Management of Dry Eye Disease
  Henry D. Perry, MD
  

Allergy

• Update on Ocular Allergy
  Terrence P. O'Brien, MD
• Ocular Allergy
  Michael B. Raizman, MD

Dry Eye

• Comparative Anti-Evaporative Effect of Commercial "Artificial Tear" Products
  James P. McCulley, MD, FACS
• Cyclosporine vs. Punctal Plugs for Relief of Dry Eye Syndrome
  Calvin W. Roberts, MD
• Management of Dry Eye Patients 2006
  Henry D. Perry, MD

• Risk Assessment for Developing Glaucoma
  Steven L. Mansberger, MD, MPH
  
• Diurnal Fluctuation and Intraocular Pressure
  Paul P. Lee, MD
  
• Clinical Trials and Target IOP
  Eydie G. Miller-Ellis, MD
  
• Optic Nerve: Pathophysiology and Examination
  Louis B. Cantor, MD
  
• Perimetry: What's New
  Steven T. Simmons, MD
  
• Summary: Integrating Gonioscopy, Risk Calculations and Diurnal Measurements into the Decision to Treat
  John R. Samples, MD
  
• Trabeculectomy: Limbal- vs. Fornix-Based Conjunctival Flaps
  L. Jay Katz, MD, FACS
  
• MMC or 5-FU: Which One, in Whom and For How Long?
  L. Jay Katz, MD, FACS
  
• Viscoelastics vs. Sutures in Trabeculectomy
  Ike K. Ahmed, MD
  
• Cataract Surgery in the Glaucoma Patient
  Louis B. Cantor, MD
  
• Phaco-NPDS: Technique
  Thomas W. Samuelson, MD
  
• Phaco-CPC: Technique
  Robert J. Noecker, MD
  
• Presbyopic IOLs in the Glaucoma Patient
  Ike K. Ahmed, MD
  
• Clinical Optic Nerve Evaluation
  L. Jay Katz, MD
  
• Practical Application of Optic Nerve Imaging in Initial Diagnosis and Progression
  Anne L. Coleman, MD, PhD PhD
  
• Imaging in Glaucoma: Limitations and Pitfalls
  Joel S. Schuman, MD
  
• New Perspectives on the Relationship Between IOP and Open Angle Glaucoma
  Kuldev Singh, MD
  
• Improving Adherence
  Mildred M.G. Olivier, MD
  
• Rational Choice of Medical Glaucoma Therapy
  Shawn J. Khan, MD, MBA, FRCSC
  
• Considerations for Drug Delivery in the Treatment of Glaucoma
  Martin B. Wax, MD
  
• Complementary and Alternative Glaucoma Treatment
  Lisa S. Gamell, MD
  
• Neuroprotection: Myth and Reality
  Christopher A. Girkin, MD, MSPH
  
• Mechanism of Action of Selective Laser Trabeculoplasty: An Update
  Jorge A. Alvarado, MD
  
• Trabeculectomy: Improving Its Effectiveness and Safety
  Dale K. Heuer, MD
  
• Aqueous Shunts
  Steven J. Gedde, MD
  
• Panel Discussion #2: Wednesday, January 18
  Moderators: Joel S. Schuman, MD; Dale K. Heuer, MD
  
• Non-Penetrating Glaucoma Surgery: Convincing the Skeptics
  Ike K. Ahmed, MD, FRCSC
  
• Glaucoma Surgical Innovations: Will Trabeculectomy Survive?
  Richard A. Lewis, MD
  
• Endoscopic and Transscleral Cyclophotocoagulation
  Robert J. Noecker, MD
  
• Cataract Surgery in the Glaucoma Patient
  Louis B. Cantor, MD
  
• Panel Discussion #3: Wednesday, January 18
  Moderators: Joel S. Schuman, MD; Dale K. Heuer, MD
  
• Hawaiian Eye Foundation's International Award Presented to Harry Brown, MD Supported by EagleVision
  Harry Brown, MD
  
• Low-Tension Glaucoma: The Clinician's Challenge
  Eve J. Higginbotham, MD
  
• Glaucoma Medications: Current and Future Potentials
  Douglas J. Rhee, MD
  
• Which Prosta Drug Should I Choose?
  David P. Tingey, MD, FRCSC
  
• Medical Therapy: Quality of Life and Cost Considerations in Choosing Medical Glaucoma Therapy
  L. Jay Katz, MD, FACS
  
• Applying Clinical Research to Patient Care
  Anne L. Coleman, MD, PhD
  
• Bleb Leaks, Blebitis, and Endophthalmitis
  Robert J. Noecker, MD, MBA
  
• Coincident Cataract and Glaucoma
  Thomas W. Samuelson, MD
  
• Filtering Surgery 1: Trabeculectomy: Tips and Tricks
  Leon W. Herndon, MD
  
• What Labs Should I Get For My Glaucoma Patients?
  Martin B. Wax, MD
  
• Medical Therapy: Quality of Life and Cost Considerations in Choosing Medical Glaucoma Therapy
  L. Jay Katz, MD, FACS
  
• Methods of Early Detection in Glaucoma
  Christopher Girkin
  
• Practical Perimetry
  Alan L. Robin, MD
  
• The Role of Structure, Function and Corneal Thickness in Glaucoma Management
  Thomas W. Samuelson, MD
  
• Keynote: Medical vs. Surgical Therapy for Glaucoma: Trends and Commentary
  Richard P. Wilson, MD
  
• Is Trabeculoplasty a First Line Therapy for Glaucoma?
  Steven J. Gedde, MD
  
• Has the Role of Trabeculectomy Changed?
  Alan S. Crandall, MD
  
• Trabeculectomy for Complex Glaucomas
  Richard P. Wilson, MD
  
• Tips and Pearls to Increase Success with Non-Penetrating Surgery
  Ike K. Ahmed, MD, FRCSC
  
• Ex-PRESS Glaucoma Shunt- Initial U.S. Experience
  Karanjit S. Kooner, MD
  
• Combined Procedures: Penetrating and Non-Penetrating
  Ike K. Ahmed, MD, FRCSC
  
• Glaucoma Drainage Implants
  Steven J. Gedde, MD
  
• Why Glaucoma is Not a Surgical Decease And Why It Should Be
  Reay H. Brown, MD
  
• Glaucoma Surgery Without a Bleb: Implanting the EyePass™ into Schlemm's Canal
  Mary G. Lynch, MD · Reay H. Brown, MD
  
• Uniform Circadian IOP Control
  Sanjay Asrani, MD
  
• The Glaucoma Clinical Trials: What Have We Learned?
  L. Jay Katz, MD, FACS
  
• Implementing What We Have Learned About Glaucoma Pharmacotherapy
  Ronald L. Gross, MD
  
• Achieving the New Targets
  Louis B. Cantor, MD
  
• Reaching the Difficult Target Pressures
  Steven T. Simmons, MD
  
• Clinical Comparison of PGs for Treatment of Glaucoma
  Martin B. Wax, MD
  
• Vascular Factors in Glaucoma
  Joel S. Schuman, MD
  
• Nonpenetrating Glaucoma Surgery
  Alan L. Robin, MD
  
• Primary Therapy for Glaucoma
  Alan L. Robin, MD
  
• Faster Fields: FDT vs. SITA
  Jonathan S. Myers, MD
  
• Adjunctive Therapy for Glaucoma
  Steven T. Simmons, MD
  
• What Would Patients Care About in a Drug?
  Henry D. Jampel, MD, MHS
  
• Coincident Cataract and Glaucoma: Has the Classic Teaching Become Obsolete?
  Thomas W. Samuelson, MD
  
• The Ocular Hypertension Treatment Study: Five Year Results
  Jeffrey M. Liebmann, MD, F.A.C.S.
  

• Amaurosis Fugax - Work Up & Treatment
  Jonathan D. Trobe, MD
  
• Central Eye Movement Disorders
  Thomas R. Hedges III, MD
  
• Idiopathic Intracranial Hypertension
  Norman J. Schatz, MD
  
• Neuro-Ophthalmology Emergencies
  Jonathan D. Trobe, MD
  
• Neuroimaging for Ophthalmologists
  Steven F. Falcone, MD, MBA
  
• OCT in Neuro-Ophthalmology
  Thomas R. Hedges III, MD
  
• Evaluating Patients with Presumed Optic Neuropathy
  Thomas R. Hedges III, MD
  
• Papilledema and Increased Intracranial Pressure
  Jonathan D. Trobe, MD
  

• Evaluation of Orbital Disorders: History and Physical Exam
  Thomas J Joly, MD, PhD
  
• Blepharoplasty Surgery for the General Ophthalmologist
  William J Lipham, MD, FACS
  
• Clinical and Cosmetic Applications of Botox
  William J Lipham, MD, FACS
  
• Q&A Session on Botox
  Doctor Panel
  
• Malignant Melanomas of the Eyelids
  Mark R Levine, M.D., F.A.C.S.
  
• Ptosis Pearls and Levator Technique
  Mark R. Levine, MD
  
• Radiosurgery and the Tarsoconjunctival flap
  Jay Justin Older, MD
  
• Brow lift or Blepharoplasty? Making the Right Choice
  Ron W. Pelton, MD, PhD
  
• Involutional Entropion
  Julian D. Perry, MD
  

Cataract and IOLs

• NSAIDs: New Agents and Changing Indications
  Edward J. Holland, MD

Corneal and Anterior Segment Disease

• Cyclosporine Therapy for Dry Eye (Cyclosporine Ophthalmic Emulsion 0.05%)
  Michael B. Raizman, MD
  
• LASIK-Associated Infections: The Next Step in Prevention and Management
  Terry Kim, MD
  
• Management of Bacterial Infections of the Cornea: Embracing the New Frontier
  Terrence P. O'Brien, MD
  
• Prevention and Management of Post-LASIK Dry Eye
  Eric D. Donnenfeld, MD
  
• Dry Eye: Is Cyclosporine the Key?
  John R. Wittpenn Jr, MD
  
• My Approach to Dry Eye
  Douglas A. Katsev, MD
  
• Topical Cyclosporine A for the Management of Dry Eye Disease
  Henry D. Perry, MD
  

Oculoplastics

• Involutional Entropion
  Julian D. Perry, MD
  

None Currently Available

• Pediatric Ophthalmology & Strabismus Update 2006
  David Granet, MD
  
• Diagnosis and Treatment of Diplopia in Adults
  Mitchell B. Strominger, MD
  
• Outcome Study of Fusion in Relation to Duration of Misalignment in Congenital Esotropia
  Malcolm R. Ing, MD
  
• Update on Pediatric Ophthalmology and Strabismus
  Mitchell B. Strominger, MD
  

• How Do We Make All of Our Patients 20/20?
  Daniel S. Durrie, MD
  
• Update on Phakic IOLs
  Elizabeth A. Davis, MD, FACS
  
• Antibiotics and NSAIDs in Corneal and Lens Surgery
  Elizabeth A. Davis, MD, FACS
  
• Decoding the Presbyopia Challenge: Building Blocks to Developing a Presbyopia-Focused Practice
  Daniel S. Durrie, MD
  
• IOL Calculations Following Corneal Refractive Surgery
  Jack T. Holladay, MD, MSEE, FACS
  
• Corneal Ectasia and Laser Refractive Surgery
  Elizabeth A. Davis, MD, FACS
  
• Anti-Infectives: Are Aminoglycosides Still Useful?
  Francis S. Mah, MD
• Contemporary Approaches to Antibiotic Selection
  Terrence P. O'Brien, MD
• The Upside of Antibiotic Potency for Killing Pathogens vs. the Downside of Clinical Toxicity
  Robert W. Snyder, MD, PhD
• Use of Fibrin Tissue Adhesive and Amnionic Membrane in Anterior Segment Surgery
  John Hovanesian, MD
• Panel Discussion - Refractive Surgical Complications
  Moderator: Richard L. Lindstrom, MD
  
• Advanced IOLs In a Refractive Surgery Practice
  Daniel S. Durrie, MD
  
• Strategies for Preventing Infection after Ophthalmic Surgical Procedures
  Francis S. Mah, MD
  
• Management Strategies for Avoidance of Infectious and Inflammatory Post Surgical Complications
  John R. Wittpenn, MD
• Adapting Your Practice to Include Wavefront LASIK Corrections: Nine Steps to Success
  David R. Hardten, MD
  
• LASEK Made Simple
  Robert W. Snyder, MD, PhD
  
• Allegretto Wave: Standard vs. Wavefront-Guided Ablation
  Raymond M. Stein, MD
  
• Screen to Prevent LASIK Disasters
  Stephen D. Klyce, PhD
  
• Super Vision: How Do We Define It? Can We Achieve It with IOLs & Corneal Refractive Surgery?
  Jack T. Holladay, MD, MSEE, FACS
  
• Effect of Rotational Malposition on Residual Aberrations
  Roger F. Steinert, MD
  
• LASEK and Epi-LASIK: An Update
  Marguerite B. McDonald, MD, FACS
  
• Making Sense of Aberrations & Visual Symptoms
  Ronald R. Krueger, MD
  
• Wavefront-Guided LASIK Treatment of Hyperopia with VISX CustomVue: Long Term Results of VISX Canadian Trial
  W. Bruce Jackson, MD, FRCSC
  
• The Quality of Vision of Wavefront Guided LASIK
  Steven C. Schallhorn
  
• The ARTISAN™ Myopia Lens: Interim Results of the U.S. FDA Clinical Study
  Kerry K. Assil, MD
  
• VISX CustomVue WMV
  Marguerite B. McDonald, MD, FACS
  
• CK^sm the Right Way
  Richard L. Lindstrom, MD
  
• Clinical Impact of Automated Cyclotorsional Registration and Tracking
  Marguerite B. McDonald, MD, FACS
  
• Expanding a Practice with Phakic Implants
  Raymond M. Stein, MD, FRCSC
  
• Where Will the ICL Fit in a Comprehensive Refractive Practice
  John A. Vukich, MD
  
• WaveScan-Guided LASIK Treatmeant of Hyperopia and Mixed Astigmatism at Kraff Eye Institute
  Manus C. Kraff, MD
  
• The ARTISAN™ Anterior Chamber Phakic Intraocular Lens: 2004 Interim Results of the U.S. FDA Study
  Edward E. Manche, MD
  
• Update on Phakic IOLs
  Elizabeth A. Davis,MD, FACS
  
• Solid State 213 nm Laser System
  Donald R. Sanders, MD, PhD
  
• Quality of Vision Dependence on Registration and "Other Things"
  James P. McCulley, MD,FACS, FRC Ophth. (U.K.)
  
• Advances in Surface Ablation
  Helen K. Wu, MD
  
• IntraLase Femtosecond Laser Vs. Mechanical Keratomes for LASIK
  Karl G. Stonecipher, MD
  
• First Year Experience with Commercially Approved Customized Ablation
  Ronald R. Krueger, MD
  
• Multifocal Ablation for Presbyopia
  W. Bruce Jackson, MD, FRCSC
  
• Pearls in Refractive Cataract Surgery
  William J. Fishkind, MD, FACS
  
• The Optics of Wavefront Sensing
  Ronald R. Krueger, MD, MSE
  
• Zyoptix Clinical Pearls
  Louis E. Probst, MD
  
• Night Vision Quality with Larger Ablation Treatment Zones
  Richard L. Lindstrom, MD
  
• CLAPIKS Contact Lens Assisted Pharmacologically Induced Keratoshapening
  J. E. McDonald II, MD
  
• Therapeutic Cases with Custom Cornea
  Stephen F. Brint, MD, FACS
  
• Advanced Applications of CK
  Louis D. Nichamin, MD
  
• Implantable Contact Lens (ICL) Complications After 250 Implantations
  Louis E. Probst, MD
  
• Epi-LASIK with the SES: An end to LASIK as We Know It?
  Louis D. Nichamin, MD
  
• Tips & Pearls for the New IntraLASIK Surgeon in Independent Practice
  Nancy A. Tanchel, MD
  
• VISX Multifocal CustomVue LASIK Trials
  Douglas D. Koch, MD
  
• LASIK in the Naval Aviator
  Steven C. Schallhorn
  
• Phakic IOLs: Current Experience
  Richard L Lindstrom, MD
  
• Presbyopic Lens Exchange
  R Bruce Wallace, III, MD
  
• Refractive Outcomes and Patient Satisfaction in Multifocal Exchange
  Kenneth J Rosenthal, MD, FACS
  
• Orbscan for LASIK Enhancements
  John A Vukich, MD
  
• A Comparison of Phase III U.S. Study Results Between Ranges of Myopic Treatment with the ARTISAN Myopia Lens
  Elizabeth A. Davis, MD
  
• An Adjustable Intraocular Lens
  Edward E. Manche, MD
  
• Artisan Phakic IOL: Phase III FDA Results
  Kerry K. Assil, MD
  
• Conductive Keratoplasty for the Correction of Low to Moderate Hyperopia: U.S. FDA Clinical Trial 12-Month Results
  Edward E. Manche, MD
  
• Hyperopic Astigmatic LASIK
  Edward E. Manche, MD
  
• Lens-related Refractive Surgery Modalities
  Howard Fine, MD
  
• New Developments in Customized Corneal Ablation
  Scott M. MacRae, MD
  
• Refractive Outcomes With Wavefront-Guided Ablations
  Terrence P. OBrian, MD
  
• The Effect of Hinge Position
  Eric Donnenfield, MD
  
• The Management of Hyperopic Overcorrections after LASIK
  Neil A. Sher, MD, FACS
  
• Use of Eyetrackers
  David R. Hardten, MD
  
• LASIK: Technique Pearls
  Richard L. Lindstrom, MD
  
• Late Onset Diffuse Lamellar Keratitis
  Helen K Wu, MD
  

• Management of Retinal Vein Occlusion in 2006
  Sharon Fekrat, MD, FACS
• New Developments in the Management of Diabetic Retinopathy
  Michael S. Ip, MD
• Macular Degeneration: 2006
  Carmen A. Puliafito, MD, MBA
• Pseudophakic Cystoid Macular Edema
  Michael S. Ip, MD
• Surgery for Macular Diseases Involving the Vitreoretinal Interface
  Allen C. Ho, MD
• Management Strategies for Avoidance of Infectious and Inflammatory Post Surgical Complications
  John R. Wittpenn, MD
• Pathobiology of AMD: Strategies for Atrophic AMD Intervention
  Steven D. Schwartz, MD
• Applying Clinical Trial Results to Clinical Practice
  Andrew P. Schachat, MD
• Risk Factors for CNV and Prevention Trials for AMD
  Allen C. Ho, MD
• Current Approaches to Macugen Use
  Henry Hudson, MD
• Macugen: Subgroup Analyses, Second Year Data, DME Results
  Donald J. D'Amico, MD
• Vision Gainers After Early Treatment of CNV with Macugen
  Polly Quiram, MD, PhD
• Panel Discussion #1: Monday, January 16, 2006
  Moderator: Carmen A. Puliafito, MD, MBA
• Ranibizumab for Treatment of Neovascula ARMD
  Carmen A. Puliafito, MD, MBA
• Experience with Intravitreal Avastin in the Treatment of AMD
  Robert L. Avery, MD
• Retaane (anecortave acetate) Update 2006
  Peter K. Kaiser, MD
• Characteristics of CNV that Respond Well to PDT
  Nancy M. Holekamp, MD
• Photodynamic Therapy for Non-AMD CNV
  Nancy M. Holekamp, MD
• VEGF Trap for AMD
  Peter K. Kaiser, MD
• Do We Still Need Fluorescein Angiograph in the Era of High Resolution OCT?
  Carmen A. Puliafito, MD, MBA
• PDT for Predominately Hemorrhagic CNV Lesions in Eyes with Neovascular AMD
  Sharon Fekrat, MD, FACS
• Selective Intraocular Brachytherapy for CNV
  Eugene de Juan, Jr., MD
• Sensory Substitution: Vision Through Electrotactile Feedback
  Michael S. Ip, MD
• Why Macular Translocation Should Not Die?
  Eugene de Juan, Jr., MD
• Nutritional Modification of AMD and Diabetic Retinopathy: Current and Emerging Concepts
  Michael J. Cooney, MD, MBA
• RNA Interference (RNAi) with Small Interfering RNA (siRNA)
  Peter K. Kaiser, MD
• Pharmacologic Therapy for AMD: A Venture Capital Perspective
  Gil Kliman, MD
• Genetics of AMD and What it Means
  Eugene de Juan, Jr., MD
• The Role of the Fundus Photograph Reading Center (University of Wisconsin) in Clinical Trials
  Michael S. Ip, MD
• Intravitreal Steroid Therapy: A Clinical and Basic Science Perspective
  Donald J. D'Amico, MD
• The Ethics of Emerging Therapies: Case Studies of Intravitreal Corticosteroid Injection
  Nancy M. Holekamp
• Intravitreal Triamcinolone for Macular Diseases (DME, CRVO, BRVO)
  Ingrid U. Scott, MD
• New Methods of Antibiotic Delivery (Microspheres, Thermal Gels, etc)
  William F. Mieler, MD
• Complications of Intravitreal Steroids
  Nancy M. Holekamp, MD
• Patterned Scanning Laser (PASCAL) for Retinal Photocogaulation
  Steven D. Schwartz, MD
• Widefield Angiography
  Steven D. Schwartz, MD
• Detection of Diabetic Foveal Edema: Contact Lens Biomicroscopy Compared with OCT
  Andrew P. Schachat, MD
• Systemic Medications and Retinal Toxicity
  William F. Mieler, MD
• New Treatments for Retinal Vein Occlusion
  Michael S. Ip, MD
• Intravitreal Avastin for the Treatment of Proliferative Diabetic Retinopathy and other Vascular Diseases
  Robert L. Avery, MD
• Changing Approaches in Vitreoretinal Surgery for Primary and Complicated Retinal Detachment
  Donald J. D'Amico, MD
• Minimally Invasive Vitreoretinal Surgery
  Eugene de Juan, Jr., MD
• Observations on the Management of Dislocated and Secondary IOLs: A Vitreoretinal Surgeon's Perspective
  Donald J. D'Amico, MD
• Radial Optic Neurotomy in the Porcine Eye Without CRVO: A Histopathologic Study
  Sharon Fekrat, MD, FACS
• 25 Gauge Surgery: Complications and Outcomes 400 Eyes
  Steven D. Schwartz, MD
• Vitrectomy with Drainage of Chronic Diabetic Cystoid Macular Edema
  Peter K. Kaiser, MD
• Xenon Dual Illumination Vitrectomy System and Bimanual Surgical Maneuvers
  Allen C. Ho, MD
• Surgical Management of Macular Retinoschisis Associated with High Myopia
  Ingrid U. Scott, MD
• Ocular Rehabilitation with Vitreoretinal Surgery in Association with Permanent Keratoprosthesis
  Donald J. D'Amico, MD
• Drug Delivery for Retinal Disease
  Eugene de Juan Jr., MD
• Posterior Segment Drug Delivery with Intravitreal Implants
  Caroline R. Baumal, MD
• Clinical Trial of a Model 1 Intraocular Retinal Prosthesis
  Eugene de Juan Jr., MD
• Ultrahigh Resolution OCT: An Advancing Technology
  Jay S. Duker, MD
• Macular Hole Surgery: An Update
  Jay S. Duker, MD
• Retained Lens Fragments After Cataract Surgery
  Ingrid U. Scott, MD
• Epi-LASIK: Histology, Clinical Outcomes, and Technique Pearls
  Marguerite B. McDonald, MD
  
• Wavefront-Guided LASIK nomograms
  Yunhee Lee, MD, MPH
  
• Refining Visual Quality Expectations for High Myopes with Wavefront-Driven Custom Ablation
  Manus C. Kraff, MD
  
• Optimized vs WFG LASIK: Which is Better?
  Steven C. Schallhorn, MD
  
• Device-Independent Interpreter of Corneal Topography
  Stephen D. Klyce, PhD
  
• Understanding Corneal and Lenticular Multifocality for the Surgical Treatment of Presbyopia
  W. Bruce Jackson, MD
  
• Wavefront-Guided Excimer Laser Surface Ablation to Treat Eyes with Significant Levels of Coma and Trefoil
  Richard L. Lindstrom, MD
  
• Cornea Reconstruction Surgery for Keratoconus and Post-LASIK Ectasia
  David J. Schanzlin, MD
  
• Problems with Penetrating Keratoplasty: Rejection, Endothelial Loss with Time, Optical Distortion
  Herbert E. Kaufman, MD
  
• Panel Discussion #1: Friday, January 20, 2006
  Moderator: Richard Lindstrom, MD
  
• Clinical Indications for Wavefront-Optimized vs. Wavefront-Guided Based on US FDA Trial Results
  Stephen F. Brint, MD
  
• Custom Upgrades: Patient Selection and Treatment Pearls
  Daniel S. Durrie, MD
  
• Corneal Ectasia After LASIK Topography and Other Risk Factors
  R. Doyle Stulting, MD, PhD
  
• Therapeutic Refractive Surgery
  Roger F. Steinert, MD
  
• LASEK to Enhance Previous LASIK
  William B. Trattler, MD
  
• Update on the Ad Hoc Committee of the AAO and ASCRS on Iatrogenic Keratectasia
  Helen K. Wu, MD
  
• Prophylactic and Therapeutic Strategies for LASIK Flap Complications
  Terry Kim, MD
  
• Complex Wavefront Retreatments
  Brian S. Boxer Wachler, MD
  
• Treatment of Induced Aberrations
  Ronald R. Krueger, MD
  
• Intralase vs. Mechanical Keratomes
  Karl G. Stonecipher, MD
  
• Light Touch CK for the Treatment of Presbyopia: Clinical Results
  Marguerite B. McDonald, MD
  
• Retreatment of Eyes with Hyperopia Following Previous Keratorefractive Surgery
  Edward E. Manche, MD
  
• Update: US Aviation Refractive Surgery Standards
  Colonel Robert E. Smith, II, MD
  
• Refractive Surgery and Glaucoma
  Thomas W. Samuelson, MD
  
• Anterior Segment Optical Coherence Tomography: Present and Potential Applications
  John A. Vukich, MD
  
• Visian ICL: Update on Hyperopia and In-Office Surgery Suite Implantation
  Paul J. Dougherty, MD
  
• Interesting Lifestyles in Ophthamology
  Scott D. Barnes
  
• Current Treatments for Age Related Macular Degeneration: 2005
  Jay S. Duker, MD
  
• Anti-VEGF Pharmacotherapy for Neovascular AMD
  Carl D. Regillo, MD
  
• RhuFab V2 Studies - Pharmacotherapy of Neovascular AMD
  Carmen A Puliafito, MD, MBA
  
• Size matters - lesion size and not lesion composition predicts verteporfin-pdt outcomes
  Andrew P. Schachat, MD
  
• PDT for Juxtafoveal CNV in Patients with AMD
  Andrew P. Schachat, MD · Karl Hagen Professor of Ophthalmology
  
• Anecortave Acetate - 12 Month Results
  Peter K. Kaiser, MD
  
• 25 Gauge Vitreous Surgery
  Steven D. Schwartz, MD
  
• Advances in the Pharmacologic and Surgical Treatment of Uveitis
  Keith A. Warren, MD
  
• Complications of PDT
  Caroline R. Baumal, MD, FRCSC
  
• Intravitreal Kenalog for Macular Edema
  Jay S. Duker, MD
  
• Macular Complications of Early-Stage (Perifoveal) Posterior Vitreous Detachment
  Mark W. Johnson, MD
  
• Medical Management of Retinal Venous Occlusive Disease
  Mark W. Johnson, MD
  
• Microbiologic Study of Materials Used for Intravitreal Injection of Triamcinolone Acetonide
  Mark W. Johnson, MD
  
• Ultra High Resolution Optical Coherence Tomography (UHR - OCT)
  Jay S. Duker, MD
  
• Panoptx® Dry Eye Comfort Study
  Richard L. Lindstrom, MD
  
• Photodynamic Therapy (PDT) for Non-AMD Disorders
  Caroline R. Baumal, MD, FRCSC
  
• Drug Delivery Platforms for AMD
  Mark S. Humayun, MD, PhD
  
• Posterior Segment Trauma
  Caroline R. Baumal, MD, FRCSC
  
• Retinal Considerations in Cataract Surgery and IOL Selection
  Carmen A. Puliafito, MD, MBA
  
• Reversal of Dry Macular Degeneration
  Jerold L. Tennant, MD
  
• Management of ROP After Laser
  Steven D. Schwartz, MD
  
• Subretinal Gas Migrations Through Optic Disc Pits - Implications for Pathogenesis
  Mark W. Johnson, MD
  
• Detection of Diabetic Foveal Edema: Contact Lens Biomicroscopy Compared with OCT
  Andrew P. Schachat, MD
  
• Long Term Results of Hyperopic and Myopic Refractive Lensectomy with the Array Multifocal Implant
  Frank A. Bucci, Jr., MD
  
• Retina: Pharmacotherapy of AMD
  Jorge G. Arroyo, MD, MPH
  
• Current Indications for Photodynamic Therapy
  Jason S Slakter, MD
  
• Anti-VEGF Therapy for Exudative AMD
  Lawrence J Singerman, MD
  
• New Therapies for Diabetic Retinopathy
  Justin L Gottlieb, MD
  
• Update on Carotenoid Supplementation
  Micheal Ip, MD
  

• MedicoLegal Issues in Refractive Surgery: Update
  Neal A. Sher, MD, FACS
  
• OSN Compliance Case Studies Quiz: Have You Been Paying Attention?
  Alan E. Reider, JD
  
• Avoiding the Most Common Causes of Litigation
  Jay S. Duker, MD
  
• Current Trends in Ophthalmic Risk Management
  Anne Menke, RN, PhD
  
• How Do Malpractice Juries Make Their Decisions: A Jury Consultant's Viewpoint
  Wendy Pluta, PhD
  
• Preventing Errors in IOL Power Calculation and Selection
  Sonia H. Yoo, MD
  
• Responding to Unanticipated Outcomes
  Anne Menke, RN, PhD
  
• Risk Management Issues in Refractive Surgery: Advertising, Pupil Size and Other Issues
  C. Gregory Tiemeier, Esq.
  
• Systems to Ensure Proper Patient and Site Selection
  Steven Gayer, MD
  
• Risk Management Issues in Vitreoretinal Disease
  Jay S. Duker, MD